Financial Toxicity Weighs Heavily on Older Adults Facing Cancer

A cancer diagnosis changes a life in ways that extend far beyond the hospital ward. Among the most insidious of these changes is the financial burden that treatment imposes, a phenomenon researchers now call financial toxicity. Like the medical toxicity of chemotherapy, financial toxicity can accumulate, spread, and damage a patient’s health in ways that clinicians are only beginning to measure systematically. A new study from Türkiye, published in Supportive Care in Cancer, offers a detailed portrait of how this burden plays out among older adults, a group whose fixed incomes and limited earning capacity make them especially vulnerable when illness strikes late in life.

The research, conducted by Hilal Altun, Fedayi Yağar, and Sema Dökme Yağar of Kahramanmaraş Sütçü İmam University, focused on 116 cancer patients aged 65 and over who sought treatment at a university hospital in Kahramanmaraş, a city in southern Türkiye. The team set out to answer three linked questions: how severe is financial toxicity in this population, how does it relate to life satisfaction, and how does it relate to quality of life? The answers carry weight not only for Turkish health policy but for any health system confronting the twin pressures of aging populations and rising cancer treatment costs.

To capture the financial dimension of the cancer experience, the researchers used the Comprehensive Score for Financial Toxicity, or COST, scale, a patient-reported outcome measure developed specifically for people with cancer. The instrument probes out-of-pocket spending, income disruption, worry about money, and the need to work or borrow to cover care. Alongside it, the team administered the Life Satisfaction Scale, a widely used measure of how people evaluate their lives as a whole, and a quality of life instrument aligned with the World Health Organization’s framework for assessing physical, psychological, social, and environmental well-being. Together, the three measures allowed the investigators to map the emotional and functional terrain that financial stress occupies in the lives of older patients.

The statistical strategy combined descriptive statistics with correlation analysis and hierarchical regression, a technique that allows researchers to test whether a variable of interest explains additional variance in an outcome after accounting for other factors. This matters because life satisfaction and quality of life in older cancer patients are shaped by many forces, from disease stage to social support, and isolating the independent contribution of financial toxicity requires controlling for those competing explanations. The approach also let the team examine how sociodemographic characteristics, such as sex, marital status, education, income, and access to a caregiver, related to the outcomes of interest.

The headline finding was sobering but nuanced. Older adult cancer patients in the sample reported moderate levels of financial toxicity, and this level was significantly correlated with both life satisfaction and quality of life. In practical terms, patients who felt more squeezed financially tended to evaluate their lives less favorably and to report lower overall well-being. The correlation does not by itself prove that money worries cause diminished well-being, since the relationship could run in either direction or reflect shared underlying causes. But the consistency of the association, and its survival within a regression framework that accounted for demographic factors, strengthens the case that financial strain is a genuine determinant of how older patients experience life with cancer.

The demographic patterns the researchers uncovered add an important layer of specificity. Female patients and married patients showed higher levels of financial toxicity than their male and unmarried counterparts. The finding for women echoes a broader international literature, including meta-analytic work on breast cancer patients, suggesting that women with cancer may face distinctive economic pressures, whether from treatment-related employment changes, caregiving responsibilities, or pre-existing income disparities. The elevated burden among married patients is more counterintuitive at first glance, but it may reflect household financial entanglements in which treatment costs strain shared resources or in which spouses’ own needs compete for the same limited income.

Just as revealing were the factors associated with better outcomes. Patients who had access to a caregiver, who had higher levels of education, and who reported higher income levels scored higher on both quality of life and life satisfaction. These results sketch a social gradient in the cancer experience that mirrors patterns documented across many health systems. Education can equip patients to navigate complex treatment decisions and health bureaucracies, while adequate income provides a buffer against the shocks that a serious illness delivers. Caregiver access, meanwhile, speaks to the practical and emotional scaffolding that families provide, a resource whose value the study’s authors and prior literature on social support both underscore.

The study’s setting gives its findings particular resonance. Kahramanmaraş was the epicenter of the devastating earthquakes of February 2023, and research on older adults displaced by those disasters has documented elevated loneliness, death anxiety, and diminished life satisfaction in the region’s aging population. The older cancer patients in this study therefore belong to a cohort that has weathered extraordinary disruption, and their financial resilience must be understood against that backdrop. Fixed pensions, reconstruction costs, and strained family resources may all amplify the financial toxicity that a cancer diagnosis introduces, making the moderate levels observed in the sample a floor rather than a ceiling for the problem.

The Turkish findings also sit within a rapidly growing global evidence base. Studies from China, Mexico, Indonesia, and the United States have converged on the conclusion that financial hardship is a common and consequential feature of cancer care for older adults, associated with psychological distress, lower quality of life, and in some contexts treatment non-adherence. Research in American populations has shown that financial hardship among cancer survivors can persist for years after diagnosis, while intervention studies, including work on financial-legal navigation for young patients, suggest that structured support can measurably reduce the burden. What the Turkish study adds is a focused look at the oldest patients, whose economic circumstances differ fundamentally from those of working-age adults.

That difference is the crux of the authors’ policy argument. Older adults, they note, generally live on fixed incomes and have little capacity to generate additional earnings when treatment costs mount. Unlike a middle-aged patient who might return to work or take on extra hours, a 75-year-old pensioner facing expensive therapy has few levers to pull. The authors therefore argue that supportive policies should be developed to prevent financial toxicity from rising in this population, whether through expanded insurance coverage, subsidies for treatment-related expenses, or systematic screening for financial distress in oncology clinics. Their study, approved by the ethics committee of Kahramanmaraş Sütçü İmam University and conducted under the principles of the Declaration of Helsinki, provides the empirical grounding for that call.

For clinicians, the message is that financial toxicity deserves a place alongside pain, nausea, and depression in routine supportive care assessment. A brief patient-reported measure like COST can be administered in minutes, and the correlations documented here suggest that identifying financially distressed patients could flag those at risk of poorer quality of life and diminished life satisfaction. For policymakers, the study is a reminder that the true cost of cancer is measured not only in hospital budgets but in the erosion of well-being among the most vulnerable patients. As populations age and cancer incidence rises worldwide, the financial dimension of the disease will only grow more prominent, and research like this offers a template for measuring it, understanding it, and ultimately softening its impact on the lives of older adults.

Subject of Research: Financial toxicity and its relationship to life satisfaction and quality of life in older adult cancer patients

Article Title: Examining the relationships between financial toxicity, life satisfaction, and quality of life levels in older adult cancer patients

Article References: Altun, H., Yağar, F., & Yağar, S. D. (2026). Examining the relationships between financial toxicity, life satisfaction, and quality of life levels in older adult cancer patients. Supportive Care in Cancer, 34(10), Article 1036. https://doi.org/10.1007/s00520-026-11292-8

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11292-8

Keywords: financial toxicity, older adults, cancer patients, life satisfaction, quality of life, supportive care, gerontology, health economics, patient-reported outcomes, Türkiye, caregivers, health policy